FOXM1 is one of these candidate genes and has been selected for further analysis because chemical inhibitors of this target molecule are already available and have been shown to limit proliferation e.g. in liver cancer cells in vivo [18,19]. This evidence concerns the gene FOXM1 and liver cancer.